A Vision for a
Life Sciences & Biotechnology Strategy
READ MORE
EUROPABIO MANIFESTO
Unleashing the full potential of Life Sciences and Biotechnology in Europe
As an association that has manufacturers of both originator and biosimilar medicines as members, EuropaBio strongly doubts that the promises of today’s Commission proposal outweigh the risks of losing investment in new medicines.
EuropaBio notes the adoption by the European Parliament of the report on EU options for improving patient access to medicines on 2 March 2017, in Brussels.